富士莱(301258) - 2022年8月3日投资者关系活动记录表

Group 1: Investor Relations Activity - The activity type is a specific object survey [1] - Participants include representatives from Dongfang Medicine and Wanjia Fund [1] - The meeting took place on August 3, 2022, from 9:00 to 9:30 AM via Tencent Meeting [1] Group 2: Key Questions and Responses - Inquiry about the price difference between pharmaceutical intermediates and health product raw materials [1] - Response indicates that the current designed production capacity is 50 tons per year for the raw material drug alpha-lipoic acid [1] - Price differences are minimal, primarily influenced by country regulations, product usage, and customer demand [1]